Compound ID | 733
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Activity against H. influenzae and S. aureus |
| Institute where first reported: | Pharmacia &Upjohn ; Pharmacia Corp.; Pfizer, USA |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |